Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

100 results
Display

Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases

Sousa-Lima I, Kim HJ, Jones J, Kim YB

Nonalcoholic fatty liver disease (NAFLD) is a major public health problem and the most common form of chronic liver disease, affecting 25% of the global population. Although NAFLD is closely...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The PNPLA3 rs738409 Variant but not MBOAT7 rs641738 is a Risk Factor for Nonalcoholic Fatty Liver Disease in Obese U.S. Children of Hispanic Ethnicity

Mansoor S, Maheshwari A, Guglielmo MD, Furuya K, Wang M, Crowgey E, Molle-Rios Z, He Z

Purpose The rs641738 C>T in membrane-bound O-acyltransferase domain-containing protein 7 (MBOAT7) is implicated, along with the rs738409 C>G polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3), in nonalcoholic fatty liver disease...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard

Jeon SK, Lee JM, Joo I, Park SJ

Objective: To investigate the diagnostic performance of quantitative ultrasound (US) parameters for the assessment of hepatic steatosis in patients with nonalcoholic fatty liver disease (NAFLD) using magnetic resonance imaging proton...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient elastography

Taibbi A, Petta S, Matranga D, Caruana G, Cannella R, Busè G, Marco VD, Midiri M, Bartolotta TV

Purpose: This study prospectively assessed the performance of liver stiffness measurements using point shear-wave elastography (p-SWE) in comparison with transient elastography (TE) in patients with biopsy-proven nonalcoholic fatty liver disease...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepcidin Levels and Pathological Characteristics in Children with Fatty Liver Disease

Tsutsumi N, Nishimata S, Shimura M, Kashiwagi Y, Kawashima H

Purpose: Hepcidin levels have previously been reported to be correlated with liver damage.However, the association between hepcidin levels and liver fibrosis in children with fatty liver disease remains unclear. This...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease

Huang SC, Su HJ, Kao JH, Tseng TC, Yang HC, Su TH, Chen PJ, Liu CJ

Background/Aims: Fatty liver disease is defined as a cluster of diseases with heterogeneous etiologies, and its definition continues to evolve. The novel conceptional criteria for metabolic dysfunction-associated fatty liver disease...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis

Xu G, Wang YM, Ying MM, Chen SD, Li ZR, Ma HL, Zheng MH, Wu J, Ding C

Background/Aims: Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease (NAFLD) characterized by hepatic steatosis, inflammation, hepatocellular injury, and fibrosis. We aimed to investigate the usefulness of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Relationship between Nonalcoholic Fatty Liver Disease and High Sensitivity C-Reactive Protein in Healthy Adults

Choi Y, Oh JE, Lee J, Shin HS, Cho YJ, Kim SH, Joe H, Yoo BW, Hong SH, Cho CY, Son DY, Shin KS

Background: Recent studies have shown that nonalcoholic fatty liver disease (NAFLD) is associated with higher levels of high sensitivity C-reactive protein (hs-CRP), a predictor of increased risk of developing cardiovascular...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Severity of hyperechoic pancreas on ultrasonography as a risk factor for glycemic progression

Oh J, Park HJ, Lee ES, Park SB, Choi BI, Ahn S

Purpose: The aim of this study was to evaluate the association between the severity of hyperechoic pancreas (HP) on ultrasonography (US) and glycemic progression. Methods: In total, 1,386 participants who underwent...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes in Liver Enzymes and Metabolic Profile in Adolescents with Fatty Liver following Exercise Interventions

Iraji H, Minasian V, Kelishadi R

Purpose: Nonalcoholic fatty liver disease (NAFLD) is the most frequent cause of chronic liver diseases in both adults and children with obesity. The aim of this study was to compare...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases

Tamaki N, Kurosaki M, Loomba R, Izumi N

An accurate evaluation of liver fibrosis is clinically important in chronic liver diseases. Mac-2 binding protein glycosylation isomer (M2BPGi) is a novel serum marker for liver fibrosis. In this review,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis

Lee NY, Shin MJ, Youn GS, Yoon SJ, Choi YR, Kim HS, Gupta H, Han SH, Kim BK, Lee DY, Park TS, Sung H, Kim BY, Suk KT

Background/Aims: Nonalcoholic fatty liver disease (NAFLD) is closely related to gut-microbiome. There is a paucity of research on which strains of gut microbiota affect the progression of NAFLD. This study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective

Soon G, Wee A

Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) is a major cause of liver fibrosis and cirrhosis. Accurate assessment of liver fibrosis is important for predicting disease outcomes and assessing therapeutic response...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy

Chang JW, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim SU

Background/Aims: The hepatic steatosis index (HSI) is a noninvasive method to assess the severity of hepatic steatosis. Antiviral therapy (AVT) can impact aspartate aminotransferase and alanine aminotransferase levels, which are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Elevated Alanine Aminotransferase in Early Pregnancy and Subsequent Development of Gestational Diabetes and Preeclampsia

Lee SM, Park JS, Han YJ, Kim W, Bang SH, Kim BJ, Park CW, Kim MY

Background: Nonalcoholic fatty liver disease (NAFLD) is now considered as a hepatic manifestation of metabolic syndrome and elevated alanine aminotransferase (ALT) is commonly related to NAFLD in the absence of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Association between Non-Alcoholic Fatty Liver Disease Fibrosis Score and Serum Low Density Lipoprotein-Cholesterol Levels in Adults with Non-Alcoholic Fatty Liver Disease

Park SB, Choi HJ, Doo SH, Jung D, Shim YN, Oh HJ

Background: Non-alcoholic fatty liver disease fibrosis score (NFS) is a scoring system applied in clinical practice to predict advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). Evidence shows...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology

Sookoian S, Pirola CJ

Despite more than two decades of extensive research focusing on nonalcoholic fatty liver disease (NAFLD), no approved therapy for steatohepatitis—the severe histological form of the disease—presently exists. More importantly, new...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH

Hydes TJ, Ravi S, Loomba R, E. Gray M

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and affects approximately one third of adults in the United States. The disease is becoming...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors associated with Advanced Bone Age in Overweight and Obese Children

Oh MS, Kim S, Lee J, Lee MS, Kim YJ, Kang KS

PURPOSE: Obese children may often present with advanced bone age. We aimed to evaluate the correlation between factors associated with childhood obesity and advanced bone age. METHODS: We enrolled 232 overweight...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Role of Soluble Adiponectin Receptor 2 in Non-Alcoholic Fatty Liver Disease in Children

Aksoy GK, Artan R, Aksoy C, Özdem S, Atalay A, Yılmaz A

PURPOSE: The incidence of non-alcoholic fatty liver disease (NAFLD) in children is gradually increasing. The aim of this study was to investigate the use of serum adiponectin and soluble adiponectin...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr